AMN Life Science Pvt. Ltd. Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • AMN Life Science Pvt. Ltd.'s estimated annual revenue is currently $17.9M per year.(i)
  • AMN Life Science Pvt. Ltd.'s estimated revenue per employee is $100,500

Employee Data

  • AMN Life Science Pvt. Ltd. has 178 Employees.(i)
  • AMN Life Science Pvt. Ltd. grew their employee count by 17% last year.

AMN Life Science Pvt. Ltd.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$56.6M56321%N/AN/A
#2
$15.6M15528%N/AN/A
#3
$17M169-11%N/AN/A
#4
$13.2M1318%N/AN/A
#5
$19.6M19510%N/AN/A
#6
$23.5M2347%N/AN/A
#7
$5.3M530%N/AN/A
#8
$13M129-25%N/AN/A
#9
$20.5M20411%N/AN/A
#10
$11.7M1166%N/AN/A
Add Company

What Is AMN Life Science Pvt. Ltd.?

AMN Life has set the highest standard of operations and production for over last 5 years offering the right combination of Global reach & Product mix. AMN Life is a 2 Star Pharmaceutical Export House manufacturing in India and marketing a wide range of formulations in the International Market. AMN Life is committed to serve global healthcare needs. We have over 300 product registrations across South-East Asia & Africa. We have aggressive product launch and promtion strategies. We are focused on reach and affordability. We have a proficient regulatory team offering ACTD & CTD compliant dossiers. We have a strong presence in Nephrology, Gastro-Intestinal, Cardiovascular, Diabetes & Anti-Biotic segments.

keywords:N/A

N/A

Total Funding

178

Number of Employees

$17.9M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AMN Life Science Pvt. Ltd. News

2022-03-22 - Tirunelveli Reader’s Mail

... 4:54:27 pm | https://www.thehindu.com/news/national/tamil-nadu/tirunelveli-readers-mail/article65089962.ece. © THG PUBLISHING PVT LTD.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A1787%N/A
#2
$12.7M178-1%N/A
#3
$28.4M17860%N/A
#4
$20.6M1785%N/A
#5
$19.9M1793%N/A